Annual Retained Earnings
-$177.98 M
-$15.49 M-9.53%
June 1, 2024
Summary
- As of February 24, 2025, NEUP annual retained earnings is -$177.98 million, with the most recent change of -$15.49 million (-9.53%) on June 1, 2024.
- During the last 3 years, NEUP annual retained earnings has fallen by -$62.24 million (-53.78%).
Performance
NEUP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$180.73 M
-$1.94 M-1.09%
December 1, 2024
Summary
- As of February 24, 2025, NEUP quarterly retained earnings is -$180.73 million, with the most recent change of -$1.94 million (-1.09%) on December 1, 2024.
- Over the past year, NEUP quarterly retained earnings has stayed the same.
Performance
NEUP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NEUP Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.5% | 0.0% |
| 3 y3 years | -53.8% | - |
| 5 y5 years | -80.4% | -75.5% |
NEUP Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +53.8% | at low | +51.6% | at low |
| 5 y | 5-year | +80.4% | at low | +76.7% | at low |
| alltime | all time | >+9999.0% | at low | +8563.7% | at low |
Neuphoria Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -$180.73 M(+1.1%) |
| Sep 2024 | - | -$178.78 M(+0.5%) |
| Jun 2024 | - | -$177.98 M(+19.5%) |
| Jun 2024 | -$177.98 M(+9.5%) | - |
| Dec 2023 | - | -$148.95 M(-8.3%) |
| Jun 2023 | -$162.48 M(+36.3%) | -$162.48 M(+26.2%) |
| Dec 2022 | - | -$128.73 M(+8.0%) |
| Jun 2022 | -$119.22 M(+3.0%) | -$119.22 M(-0.1%) |
| Dec 2021 | - | -$119.39 M(+3.2%) |
| Jun 2021 | -$115.74 M(+13.1%) | -$115.74 M(+3.5%) |
| Dec 2020 | - | -$111.82 M(+9.3%) |
| Jun 2020 | -$102.30 M(+3.7%) | -$102.30 M(-0.7%) |
| Dec 2019 | - | -$102.97 M(+4.4%) |
| Jun 2019 | -$98.65 M(+2.2%) | -$98.65 M(-1.6%) |
| Dec 2018 | - | -$100.28 M(+3.9%) |
| Jun 2018 | -$96.49 M(+16.1%) | -$96.49 M(+5.7%) |
| Dec 2017 | - | -$91.29 M(+9.8%) |
| Jun 2017 | -$83.14 M(+7.9%) | -$83.14 M(+2.3%) |
| Dec 2016 | - | -$81.29 M(+5.5%) |
| Jun 2016 | -$77.05 M(+16.0%) | -$77.05 M(+9.9%) |
| Dec 2015 | - | -$70.09 M(+5.6%) |
| Jun 2015 | -$66.40 M(+1.3%) | -$66.40 M(+7.8%) |
| Dec 2014 | - | -$61.60 M(-6.0%) |
| Jun 2014 | -$65.54 M(-1.4%) | -$65.54 M(-7.7%) |
| Dec 2013 | - | -$71.05 M(+6.9%) |
| Jun 2013 | -$66.46 M | -$66.46 M(-4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | -$69.46 M(+8.0%) |
| Jun 2012 | -$64.29 M(+0.8%) | -$64.29 M(-0.4%) |
| Dec 2011 | - | -$64.54 M(+1.2%) |
| Jun 2011 | -$63.79 M(+42.1%) | -$63.79 M(+9.5%) |
| Dec 2010 | - | -$58.27 M(+29.8%) |
| Jun 2010 | -$44.90 M(+24.7%) | -$44.90 M(+2.7%) |
| Dec 2009 | - | -$43.73 M(+21.4%) |
| Jun 2009 | -$36.01 M(-0.3%) | -$36.01 M(+22.8%) |
| Dec 2008 | - | -$29.32 M(-18.8%) |
| Jun 2008 | -$36.13 M(+29.2%) | -$36.13 M(+12.6%) |
| Dec 2007 | - | -$32.10 M(+14.8%) |
| Jun 2007 | -$27.97 M(+36.9%) | -$27.97 M(+16.6%) |
| Dec 2006 | - | -$23.98 M(+17.4%) |
| Jun 2006 | -$20.43 M(+22.6%) | -$20.43 M(+11.5%) |
| Dec 2005 | - | -$18.31 M(+9.9%) |
| Jun 2005 | -$16.67 M(+38.4%) | -$16.67 M(+11.4%) |
| Dec 2004 | - | -$14.97 M(+24.3%) |
| Jun 2004 | -$12.04 M(+30.9%) | -$12.04 M(+3.3%) |
| Dec 2003 | - | -$11.65 M(+26.7%) |
| Jun 2003 | -$9.20 M(+79.3%) | -$9.20 M(+41.7%) |
| Dec 2002 | - | -$6.49 M(+26.6%) |
| Jun 2002 | -$5.13 M(+78.8%) | -$5.13 M(+38.1%) |
| Dec 2001 | - | -$3.71 M(+29.5%) |
| Jun 2001 | -$2.87 M(+105.3%) | -$2.87 M(+37.5%) |
| Dec 2000 | - | -$2.09 M |
| Jun 2000 | -$1.40 M(+127.2%) | - |
| Jun 1999 | -$614.80 K | - |
FAQ
- What is Neuphoria Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics annual retained earnings year-on-year change?
- What is Neuphoria Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics quarterly retained earnings year-on-year change?
What is Neuphoria Therapeutics annual retained earnings?
The current annual retained earnings of NEUP is -$177.98 M
What is the all time high annual retained earnings for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high annual retained earnings is -$614.80 K
What is Neuphoria Therapeutics annual retained earnings year-on-year change?
Over the past year, NEUP annual retained earnings has changed by -$15.49 M (-9.53%)
What is Neuphoria Therapeutics quarterly retained earnings?
The current quarterly retained earnings of NEUP is -$180.73 M
What is the all time high quarterly retained earnings for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high quarterly retained earnings is -$2.09 M
What is Neuphoria Therapeutics quarterly retained earnings year-on-year change?
Over the past year, NEUP quarterly retained earnings has changed by $0.00 (0.00%)